Treatment with infliximab (Remicade) appears to reduce the insulin resistance that is common among patients with autoimmune connective tissue diseases.
Read More »Metabolic Syndrome Accounts For $4 of every $10 Spent on RXs
Annual prescription costs for people 20 and older with metabolic syndrome averaged $4,116 last year, 4.2 times the average amount spent on drugs for that age group.
Read More »Too Much fat Causes Liver Disease
Obese people may be “super-sizing” more than just their waistline.
Read More »Exercise In Cold Water Increases Appetite
Results indicate people may consume more calories after exercising in cold water.
Read More »Impact of MI & Diabetes on Overall Health Differs Between the Sexes
In men myocardial infarction increases the risk of death from heart disease more so than diabetes, but in women diabetes is a greater mortality threat.
Read More »Cost-Effectiveness of Irbesartan in Diabetic Nephropathy
A systematic review of published studies over 10 years
Read More »Alter Your DNA Linked to Diabetes and CVD With Exercise
They found that many activated genes are likely linked to diabetes and cardiovascular disease.
Read More »FDA OKs Lilly-Amylin Drug Byetta for Type 2 Diabetes
A drug derived from lizard saliva has been approved by U.S. regulators to treat diabetes in patients who have not responded to other treatments, the drug’s developers, Eli Lilly and Co. and Amylin Pharmaceuticals Inc., said on Friday. See special this week’s feature. Lizard Spit leads to Improved Glucose Control
Read More »Physical Activity Not Just for Those With Diabetes
Exercise and Well-Being: A Review of Mental and Physical Health Benefits Associated With Physical Activity
Read More »Glycemic Control Continues to Deteriorate After Sulfonylureas Are Added
Glycemic control is improved following the addition of SUs to MF, but deterioration resumes as early as 6 months.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.